Literature DB >> 12855002

A homogeneous nonisotopic histone deacetylase activity assay.

Birgit Heltweg1, Manfred Jung.   

Abstract

Histone deacetylases (HDACs) are important regulators of transcription, and their inhibitors are a promising class of anticancer agents. The methods for the determination of HDAC activity and its inhibition that are currently available suffer from various drawbacks, such as animal testing, radioactive substrates, or limited throughput. Therefore, a fast nonisotopic method for the measurement of HDAC activity is highly desirable. The authors present such an assay that relies on the fluorescent HDAC substrate developed previously in their group. After incubation of the substrate with the enzyme, a derivatization leads to efficient fluorescence quenching in the deacetylated metabolite. Thus, only the fluorescence emitted by the remaining substrate is detected, which allows for a convenient detection of HDAC activity in a homogeneous format that can be performed on multiwell plate readers. This procedure, called HDASH (histone deacetylase assay-homogeneous), should be a valuable tool in transcriptional research and especially drug discovery.

Mesh:

Substances:

Year:  2003        PMID: 12855002     DOI: 10.1177/1087057102239644

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  7 in total

Review 1.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

Review 2.  Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.

Authors:  Sabnam Parbin; Swayamsiddha Kar; Arunima Shilpi; Dipta Sengupta; Moonmoon Deb; Sandip Kumar Rath; Samir Kumar Patra
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

3.  Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6.

Authors:  Gary K Scott; Corina Marx; Crystal E Berger; Laura R Saunders; Eric Verdin; Stefan Schäfer; Manfred Jung; Christopher C Benz
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

4.  Improved mass spectrometry-based activity assay reveals oxidative and metabolic stress as sirtuin-1 regulators.

Authors:  Di Shao; Chunxiang Yao; Maya H Kim; Jessica Fry; Richard A Cohen; Catherine E Costello; Reiko Matsui; Francesca Seta; Mark E McComb; Markus M Bachschmid
Journal:  Redox Biol       Date:  2019-03-05       Impact factor: 11.799

5.  Osthole extracted from a citrus fruit that affects apoptosis on A549 cell line by histone deacetylasese inhibition (HDACs).

Authors:  Hamed A Abosharaf; Thoria Diab; Faten M Atlam; Tarek M Mohamed
Journal:  Biotechnol Rep (Amst)       Date:  2020-09-22

6.  Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.

Authors:  A Vogelmann; M Schiedel; N Wössner; A Merz; D Herp; S Hammelmann; A Colcerasa; G Komaniecki; J Y Hong; M Sum; E Metzger; E Neuwirt; L Zhang; O Einsle; O Groß; R Schüle; H Lin; W Sippl; M Jung
Journal:  RSC Chem Biol       Date:  2022-03-01

7.  First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement.

Authors:  Daniel Herp; Johannes Ridinger; Dina Robaa; Stephen A Shinsky; Karin Schmidtkunz; Talha Z Yesiloglu; Theresa Bayer; Raphael R Steimbach; Corey J Herbst-Gervasoni; Annika Merz; Christophe Romier; Peter Sehr; Nikolas Gunkel; Aubry K Miller; David W Christianson; Ina Oehme; Wolfgang Sippl; Manfred Jung
Journal:  Chembiochem       Date:  2022-06-10       Impact factor: 3.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.